FDA panel recommends limiting Pfizer booster shots to Americans 65 and older, and those at high risk of severe COVID-19

An FDA panel has voted against recommending approval of a booster COVID-19 shot for the general population – disappointing some public health officials.

© La Conversation - vendredi 17 septembre 2021